CA

David James Phipps


Average Co-Inventor Count = 8.0

ph-index = 3

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 1998-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: David James Phipps: Innovator in Peptide Research

Introduction

David James Phipps is an accomplished inventor based in Ontario, Canada, recognized for his significant contributions to the field of peptide research. With a strong emphasis on innovative treatments for inflammation and multiple sclerosis, he holds three patents that exemplify his expertise and dedication to advancing medical science.

Latest Patents

Phipps' latest patents revolve around the use of Peptide T and related peptides in treating inflammation, including multiple sclerosis. His work details a method for treating inflammation in patients by administering an effective amount of a peptide denoted by the general formula I-A-B-C-D-E-F-G-H-II. Each component of the formula is carefully selected from amino acids such as Ala, Gly, Val, Ser, and others, allowing for a versatile approach to therapy. At least one amino acid may also be substituted with a carbohydrate or its derivative, enhancing the therapeutic potential of his peptides. His patents reflect a sophisticated understanding of biochemistry, aiming to provide effective treatments for patients in need.

Career Highlights

Throughout his career, David James Phipps has worked with notable companies including Advanced Immuni T, Inc. and Peptide Technology Limited. His positions in these organizations have allowed him to explore cutting-edge research and contribute to groundbreaking developments in peptide technology. His inventive mindset and persistent efforts have positioned him as an influential figure in the realm of biomedical innovation.

Collaborations

Collaboration has been a key component of Phipps’ success. He has worked alongside esteemed colleagues such as Anders Jorgen Andersen and Roger Aston, pooling their expertise to drive advancements in peptide therapies. This teamwork reflects the interconnected nature of scientific research and the importance of shared knowledge in fostering innovation.

Conclusion

David James Phipps stands out as an inventive force in the development of peptide-based treatments for inflammation and multiple sclerosis. His patents not only showcase his creativity and technical skill but also signify hope for improved therapeutic options for those affected by these conditions. As he continues to progress in his career, Phipps will undoubtedly contribute further to the landscape of healthcare through his innovative approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…